Drug pricing scheme ‘must be more transparent’, says commissioning chief


The deal struck between the government and the pharmaceutical industry to limit the amount the NHS spends on branded drugs must become ‘more transparent’, the director of NHS Clinical Commissioners has said.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of HSJ.co.uk and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here